| Issue |
MATEC Web Conf.
Volume 372, 2022
International Conference on Science and Technology 2022 “Advancing Science and Technology Innovation on Post Pandemic Through Society 5.0” (ICST-2022)
|
|
|---|---|---|
| Article Number | 02001 | |
| Number of page(s) | 4 | |
| Section | Advance Material and Interface | |
| DOI | https://doi.org/10.1051/matecconf/202237202001 | |
| Published online | 08 December 2022 | |
Functional Effect of Lesser Yam Symbiotic Yoghurt on Hypercholesterolemia Wistar Rats
1 Food Technology Department, Engineering Faculty, UPN Veteran Jawa Timur Indonesia
2 Chemical Engineering Department, Engineering Faculty, UPN Veteran Jawa Timur Indonesia
* Corresponding author: rosidaupnjatim@gmail.com
Synbiotic lesser yam yoghurt is fermented drink made from the mixture of cow’s milk and lesser yam extract which has functional benefits. Lesser yam yoghurt contains lactic acid bacteria, lactic acid, inulin, and soluble fiber which can improve the lipid profile of hypercholesterolemia sufferers. This study aims to determine the effect of the intake of lesser yam yoghurt on the lipid profile of hypercholesterolemia wistar rats. This study used nested randomized design with two factors, the first factor was a feeding group (0,1,2,3,4 ml/day, while the second factor was the time of blood collection (0, week 1 and week 2). The data obtained were analyzed by using ANAVA and further test DMRT (Duncan Multiple Range Test) with a level of 5%. The results showed that giving lesser yam yoghurt for 2 weeks had a significant effect on the lipid profile improvement. Rats from 4 ml of yoghurt treatment experienced a decrease in total serum cholesterol by 48.4%, triglyceride levels by 35.8% and LDL levels by 65,5% and an increase in serum HDL levels by 150.3%. So it can be concluded that the intake of synbiotik lesser yam yoghurt has functional benefits in improving the lipid profile of hypercholesterolemia rats.
Key words: hypercholesterolemia rats / synbiotic yoghurt / lesser yam tubers / lipid profile
© The Authors, published by EDP Sciences, 2022
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.